Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary endpoint of superior A1C reduction vs. placebo at 40 weeks.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Eli Lilly's oral GLP-1 drug orforglipron met key Phase 3 goals in type 2 diabetes, lowering A1C and weight with a favorable ...

The active pharmaceutical ingredient (API) in Mounjaro, the weight-loss drug produced by Eli Lilly, is Ireland’s biggest pharmaceutical export to the US, and would be the hardest hit if US ...

We recently published a list of Starter Stock Portfolio 12 Safe Stocks to Buy. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best beginner ...

Eli Lilly has recently announced several developments, including positive Phase 2 results for their siRNA therapy lepodisiran and the expansion of their digital healthcare platform, LillyDirect ...

On Friday, shares of Eli Lilly & Co (NYSE:LLY). and Novo Nordisk (NYSE:NVO) A/S experienced declines in after-hours trading following the Trump administration’s decision not to proceed with a ...

The boss of Eli Lilly, one of the biggest pharmaceutical companies in the world, has called US President Trump's tariffs a pivotal moment in US economic history, saying it will be hard to go back ...

Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...